AU5522996A - Hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemic traits - Google Patents

Hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemic traits

Info

Publication number
AU5522996A
AU5522996A AU55229/96A AU5522996A AU5522996A AU 5522996 A AU5522996 A AU 5522996A AU 55229/96 A AU55229/96 A AU 55229/96A AU 5522996 A AU5522996 A AU 5522996A AU 5522996 A AU5522996 A AU 5522996A
Authority
AU
Australia
Prior art keywords
hydroxynonyladenine
traits
ischemic
analogs
enhanced lipophilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55229/96A
Other languages
English (en)
Inventor
Elie Abushanab
Jerzy A. Barankiewicz
Anne M. Danks
Lewis R Makings
Paul J. Marangos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt ARD Inc
Original Assignee
Cypros Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cypros Pharmaceuticals Corp filed Critical Cypros Pharmaceuticals Corp
Publication of AU5522996A publication Critical patent/AU5522996A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU55229/96A 1996-02-12 1996-02-12 Hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemic traits Abandoned AU5522996A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002199615A CA2199615A1 (en) 1996-02-12 1996-02-12 Erythro-hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemia traits
PCT/US1996/001990 WO1997028803A1 (en) 1996-02-12 1996-02-12 Hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemic traits

Publications (1)

Publication Number Publication Date
AU5522996A true AU5522996A (en) 1997-08-28

Family

ID=25679111

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55229/96A Abandoned AU5522996A (en) 1996-02-12 1996-02-12 Hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemic traits

Country Status (4)

Country Link
EP (1) EP0871449A1 (enrdf_load_stackoverflow)
AU (1) AU5522996A (enrdf_load_stackoverflow)
CA (1) CA2199615A1 (enrdf_load_stackoverflow)
WO (1) WO1997028803A1 (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP921299A0 (en) 1999-03-15 1999-04-15 Fujisawa Pharmaceutical Co., Ltd. New heterocyclic compounds
DE102015009609B4 (de) 2015-07-22 2024-08-22 Thomas Podzuweit Glykostimulatorische Therapie von Krebs und Metastasen: Biologisch-metabolische Krebsabwehr

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1530912A (en) * 1975-02-13 1978-11-01 Wellcome Found Compositions containing 9-(2-hydroxy-3-alkyl)-adenines
US4221909A (en) * 1978-09-15 1980-09-09 Sloan-Kettering Institute For Cancer Research P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
US5491146A (en) * 1993-01-14 1996-02-13 Cypros Pharmaceutical Corporation Hydroxylated erythro-hydroxynonyladenines and related analogs
WO1994017809A1 (en) * 1993-02-03 1994-08-18 Gensia, Inc. Adenosine deaminase inhibitor therapies

Also Published As

Publication number Publication date
CA2199615A1 (en) 1997-08-14
EP0871449A1 (en) 1998-10-21
WO1997028803A1 (en) 1997-08-14
EP0871449A4 (enrdf_load_stackoverflow) 1998-10-21

Similar Documents

Publication Publication Date Title
GB2319515B (en) Corkscrew
AU137415S (en) Corkscrew
PL331523A1 (en) Azolotrizines and azolopyrimidines
DE69733540D1 (en) Plasmid
AU5522996A (en) Hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemic traits
GB9625686D0 (en) Tapered speeddeck
AUPN976996A0 (en) Anti-rebound bar and footrest
GB9712811D0 (en) Amido furandione derivatives
GB9715957D0 (en) Bike ashraf 50
GB9722743D0 (en) Corkscrew
TW327853U (en) Folder structure
IL134499A0 (en) Pyrimidin-2- oxy-4-one and pyrimidin-2-oxy- 4-thione derivatives
GB9604636D0 (en) Comfy carrie
CA78020S (en) Type font
CA82609S (en) Corkscrew
GB2319216B (en) Stationery sets
TW300510U (en) Improved folder structure
TW308120U (en) Improved folder structure
TW296695U (en) Improved pen structure
GB9624634D0 (en) Stationery
GB9619748D0 (en) Flagpole
GB9620124D0 (en) Bike Ashraf 50
CA75549S (en) Corkscrew
CA75550S (en) Corkscrew
AU133190S (en) Corkscrew